Hilkka Soininen on New Definition of Alzheimer’s Hinges on Biology, Not Symptoms
COMMENT In Finland, we are widely using biomarkers of AD in clinical work, in particular MRI and CSF biomarkers. The new framework emphasizing the biomarkers irrespective of clinical symptoms in detecting AD early in research settings is very welcome. These are ...